nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.02.2016 | editorial

Never too old to treat cancer?

Challenges in treating elderly and very old cancer patients

verfasst von: Univ.-Prof. Dr. Michael Pfeilstöcker, MBA

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Modern medicine has largely contributed to the remarkable increase in life expectancy in developed countries. On the other hand, this progress has also created new challenges. During the normal life span, an increasing cumulative acquisition of clonal genetic changes can be observed that predisposes to cancer and leads to the fact that cancer by itself is a predominant disease of the elderly [1]. …

Vorheriger Artikel Open Access publizieren in „memo – magazine of european medical oncology“

Nächster Artikel Treatment of elderly and very old patients with AML

Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371:2488–98.CrossRefPubMedPubMedCentral

Greenberg PL, Tuechler H, Schanz J, et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood. 2012;120(12):2454–65.CrossRefPubMedPubMedCentral

Berdel WE, Müller-Tidow C, Krug U. AML score. http://www.aml-score.org.

Hamaker ME, Prins MC, Stauder R. The relevance of a geriatric assessment for elderly patients with a haematological malignancy—a systematic review. Leuk Res. 2014;38(3):275–83.CrossRefPubMed

Pfeilstöcker M. Sind Methodik und Ergebnisse klinischer Studien relevant für Patienten mit Myelodysplastischen Syndromen? 2011, Masterthesis, MBA in Health Care Management, Vienna University of Economics.

Burgstaller S, Wiesinger P, Stauder R. Myelodysplastic syndromes in the elderly: treatment options and personalized management. Drugs Aging. doi:10.1007/s40266-015-0312-7

Titel: Never too old to treat cancer?
Challenges in treating elderly and very old cancer patients
verfasst von: Univ.-Prof. Dr. Michael Pfeilstöcker, MBA
Publikationsdatum: 01.02.2016
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2016
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-016-0251-y

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2016

Open Access publizieren in „memo – magazine of european medical oncology“

Adjuvant medical treatment for breast cancer in elderly and old women

Treatment of elderly patients with melanoma

Erratum to: A review on biomolecular basis of the role of psychological stress in the development and progression of cancer

TruSight Cancer Sequencing Panel reveals pharmacogenetic variants associated with sensitivity to chemotherapy in lung cancer

New approaches in graft versus host disease (GvHD) management